Cathie Wood acquired 6.94 Million Twist Bioscience shares worth $205 Million. That's 1.67% of their equity portfolio (17th largest holding). The investor owns 12.47% of the outstanding Twist Bioscience stock. The first Twist Bioscience trade was made in Q4 2019. Since then Cathie Wood bought shares eleven more times and sold shares on six occasions. The investor's estimated purchase price is $443 Million, resulting in a loss of 54%.
https://www.investing.com/news/company-news/cathie-woods-ark-etfs-buy-roku-twist-bioscience-stock-93CH-3377199
Investing.com, 11 days agoGenomics is undeniably medicine’s future, and genomics stocks stand to be the next big thing in healthcare as the industry matures. But the crux of the matte...
InvestorPlace, 4 months agoCathie Wood''s Ark Invest may have had a disappointing 2021 , but the fund''s purchases/liquidations are always watched keenly by investors. On Friday, ETFs ...
Benzinga, about 2 years ago